Send the following on WhatsApp
Continue to Chat必治妥施貴寶 1.5 億收購雙特異性 TCR 療法,擴大癌症免疫戰局 https://geneonline.news/bristol-myers-squibb-tcr-acquisition/?variant=zh-cn
必治妥施貴寶 1.5 億收購雙特異性 TCR 療法,擴大癌症免疫戰局 https://geneonline.news/bristol-myers-squibb-tcr-acquisition/?variant=zh-cn